This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA345618; GEO: GSE87716 |
| Type | Umbrella project |
| Publications | Alzrigat M et al., "EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.", Oncotarget, 2017 Feb 7;8(6):10213-10224 |
| Submission | Registration date: 6-Oct-2016
IGP, Rudbeck Laboratory, Uppsala University |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 409510 |
| Data volume, Processed Mbytes | 11 |
| Data volume, Supplementary Mbytes | 161 |
EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA345622 | Homo sapiens | EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions [miRNA expression] (IGP, Rudbeck Laboratory,...) | | PRJNA345623 | Homo sapiens | EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions [mRNA expression] (IGP, Rudbeck Laboratory,...) |
|